Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

NITROFURANTOIN MCR 100 MG CAP

Nitrofurantoin macrocrystals
$0.2485per EA

Strength

100 mg/1

Manufacturer

Lupin Pharmaceuticals Inc.

NDC

43386064201

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

NITROFURANTOIN

Approval Type

Generic (ANDA)

FDA Application

ANDA203233

On Market Since

7/9/2018

Pharmacological Classes

Nitrofuran Antibacterial
Nitrofurans

Price History

1W

0.0%

1M

+4.8%

3M

+4.2%

6M

+9.4%

1Y

-5.7%

3Y

-32.9%

5Y

N/A

All

-48.7%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

NITROFURANTOIN MCR 50 MG CAP
Generic
00115164301•Amneal Pharmaceuticals of New York LLC
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
00904702661•Major Pharmaceuticals
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
50268062315•AvPAK
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
59651075301•Aurobindo Pharma Limited
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
60687083901•American Health Packaging
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
62332039031•Alembic Pharmaceuticals Inc.
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
68001060400•BluePoint Laboratories
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
68382055901•Zydus Pharmaceuticals (USA) Inc.
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
70756041111•Lifestar Pharma LLC
$0.1411
per EA
NITROFURANTOIN MCR 50 MG CAP
Generic
72603018301•NorthStar Rx LLC
$0.1411
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy